Alison Ehrlich
Dermatology · Chevy Chase, MDNPI 1750376497
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Johnson & Johnson at 51.2% of the total. Reporting peaked in 2022 at $40,963 and has fallen 99.5% since, to $213 in 2025. Among dermatology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $627.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$83K
- Janssen Scientific Affairs, LLC$30K
- Bristol Myers Squibb$12K
- UCB, Inc.$11K
- Amgen$10K
- LEO Pharma Inc.$8K
- plus $8K from 18 others
Across 78 payments — averaging $5142.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$112K
- Eli Lilly$109K
- UCB SA$77K
- Amgen$54K
- Sanofi US Services Inc.$28K
- Bristol Myers Squibb$15K
- plus $7K from 5 others
What the payments were for
- Consulting fees$57,93836%
- Speaking & faculty fees$84,72052%
- Travel & lodging$13,4458%
- Food & beverage$6,4334%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 83 | $83,235 |
| Janssen Scientific Affairs, LLC | 26 | $30,214 |
| Bristol Myers Squibb | 16 | $12,445 |
| UCB, Inc. | 21 | $10,563 |
| Amgen | 23 | $10,007 |
| LEO Pharma Inc. | 10 | $7,839 |
| Hexal AG | 1 | $3,500 |
| E.r. Squibb & Sons, L.L.C. | 9 | $2,542 |
| AbbVie(2 entities) | 19 | $925 |
| Pfizer | 14 | $328 |
| Sanofi | 6 | $156 |
| Galderma Laboratories, L.p. | 7 | $141 |
| Novartis | 2 | $139 |
| Dermavant Sciences, Inc. | 1 | $114 |
| Biofrontera Inc. | 2 | $110 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $60 |
| Verrica Pharmaceuticals Inc. | 3 | $52 |
| Encore Dermatology Inc. | 3 | $48 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| Almirall LLC | 2 | $41 |
| Merz North America, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$162,644 in reported general payments places this provider in the 95th percentile of 306 dermatology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 11 | $189,457 |
| Dupixent PenDupilumab | 16 | $67,792 |
| Fluocinonide | 31 | $1,701 |
| Metronidazole | 11 | $730 |
| Ketoconazole | 11 | $146 |
| Triamcinolone Acetonide | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $83,235 | $189,45711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 306 dermatology providers in Maryland.
Other dermatology in Chevy Chase
- Rebecca KazinChevy Chase$342K
- Pantea TamjidiChevy Chase$100K
- Gary PeckChevy Chase$14K
- Mana OgholikhanChevy Chase$13K
- Benjamin LockshinSilver Spring$4M
- Shawn KwatraBaltimore$1.1M
- Chesahna Kindred WeaverMarriottsville$837K
- Oanh LauringNottingham$763K
- Ronald PrussickN Bethesda$620K
- Susan WalkerBethesda$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.